Anja S. Muhlfeld

Aachen, NW, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 38 publications

Safety and efficacy of rituximab-free ABO incompatible kidney transplantation: a German multicenter cohort study.

Safety and efficacy of rituximab-free ABO incompatible kidney transplantation: a German multicenter cohort study.

Journal: Frontiers in nephrology

Published: June 03, 2026

Risk-adapted HLA delisting and imlifidase-enabled deceased-donor kidney transplantation in highly sensitized kidney transplant candidates: a German expert consensus report.

Risk-adapted HLA delisting and imlifidase-enabled deceased-donor kidney transplantation in highly sensitized kidney transplant candidates: a German expert consensus report.

Journal: Frontiers in immunology

Published: April 02, 2026

ABO-incompatible kidney transplantation with high isoagglutinin titres: practice pattern and problem solving: a German multi-centre survey.

ABO-incompatible kidney transplantation with high isoagglutinin titres: practice pattern and problem solving: a German multi-centre survey.

Journal: Frontiers in immunology

Published: March 16, 2026

Differing effects of Nefecon and Sparsentan in a patient with recurrent IgA nephropathy post-kidney transplantation.

Differing effects of Nefecon and Sparsentan in a patient with recurrent IgA nephropathy post-kidney transplantation.

Journal: Clinical kidney journal

Published: February 14, 2026

Revisiting clinical response and refractoriness in immune thrombotic thrombocytopenic purpura.

Revisiting clinical response and refractoriness in immune thrombotic thrombocytopenic purpura.

Journal: Blood

Published: October 14, 2025

Revisiting Clinical Response and Refractoriness in Immune Thrombotic Thrombocytopenic Purpura.

Revisiting Clinical Response and Refractoriness in Immune Thrombotic Thrombocytopenic Purpura.

Journal: Blood

Published: October 14, 2025

External validation of a prognostic model predicting renal graft function one year after brain-dead donor kidney transplantation.

External validation of a prognostic model predicting renal graft function one year after brain-dead donor kidney transplantation.

Journal: Langenbeck's archives of surgery

Published: September 22, 2025

External validation of a prognostic model predicting renal graft function one year after brain-dead donor kidney transplantation.

External validation of a prognostic model predicting renal graft function one year after brain-dead donor kidney transplantation.

Journal: Langenbeck's archives of surgery

Published: September 22, 2025

Characteristics and Management of Patients With Immune Thrombotic Thrombocytopenic Purpura Admitted to the Intensive Care Unit: A Multicenter Retrospective Analysis.

Characteristics and Management of Patients With Immune Thrombotic Thrombocytopenic Purpura Admitted to the Intensive Care Unit: A Multicenter Retrospective Analysis.

Journal: American journal of hematology

Published: August 07, 2025

Management of immune thrombotic thrombocytopenic purpura without therapeutic plasma exchange.

Management of immune thrombotic thrombocytopenic purpura without therapeutic plasma exchange.

Journal: Blood

Published: December 27, 2023

Rescue Allocation Modes in Eurotransplant Kidney Transplantation: Recipient Oriented Extended Allocation Versus Competitive Rescue Allocation-A Retrospective Multicenter Outcome Analysis.

Rescue Allocation Modes in Eurotransplant Kidney Transplantation: Recipient Oriented Extended Allocation Versus Competitive Rescue Allocation-A Retrospective Multicenter Outcome Analysis.

Journal: Transplantation

Published: December 11, 2023

Impact of first-line use of caplacizumab on treatment outcomes in immune thrombotic thrombocytopenic purpura.

Impact of first-line use of caplacizumab on treatment outcomes in immune thrombotic thrombocytopenic purpura.

Journal: Journal of thrombosis and haemostasis : JTH

Published: July 01, 2022

Showing 1-12 of 38

Last Updated: 09/26/2026